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Morphine modulates proliferation of kidney fibroblasts. Renal inter-
stitial scarring is an important component of heroin-associated nephrop-
athy. Kidney fibroblasts have been demonstrated to play a role in the
development of renal scarring in a variety of renal diseases. We studied
the effect of morphine, an active metabolite of heroin, on the proliferation
of kidney fibroblasts. Morphine at a concentration of 10212 M enhanced
(P , 0.001) the proliferation of kidney fibroblasts (control, 67.5 6 2.0 vs.
morphine, 112.2 6 10.1 3 104 cells/well). [3H]thymidine incorporation
studies further confirmed these results. Morphine at concentrations of
10212 M to 10210 M also modulated mRNA expression of early growth
related genes (c-fos, c-jun and c-myc). Morphine at concentrations of 1028
to 1024 M promoted apoptosis of kidney fibroblasts and also enhanced the
synthesis of p53 by kidney fibroblasts. We speculate that morphine-
induced kidney fibroblast proliferation may be mediated through the
activation of early growth related genes, whereas morphine induced
kidney fibroblast apoptosis may be mediated through the generation of
p53. The present in vitro study provides a hypothetical basis for the role of
morphine in the development of renal interstitial scarring in patients with
heroin-associated nephropathy.
Heroin-associated focal glomerulosclerosis is accompanied by
interstitial fibrosis [1, 2]. Renal interstitial fibrosis has also been
demonstrated to be a better marker of renal disease progression
than glomerular scarring in a variety of renal diseases [3, 4].
Recently, the mechanism of heroin associated glomerular lesions
has been investigated in depth [5–10]. However, the role of heroin
in the induction of interstitial fibrosis has not been investigated
[5].
Kunico et al suggest that normal wound healing serves as a
model for the development of tissue fibrosis [11]. Muller et al also
emphasize that the same process may be operating in the devel-
opment of renal fibrogenesis [12]. The wound healing process
consists of three phases: induction of tissue injury, inflammation
with deposition of extracellular matrix, and resolution of the
inflammatory process. In the case of renal injury there may be an
immunologic mechanism involving glomeruli, tubulointerstitium,
or vasculature resulting in an influx of mononuclear cells, pre-
dominantly CD41 T-lymphocytes (induction phase). Infiltration
of these activated cells causes a local release of chemokines, which
not only perpetuates the accumulation of these cells but also
invites fibroblasts to become a major player in the process. In
addition, the release of cytokines activates resident fibroblasts
[13]. Activated fibroblasts proliferate and synthesize matrix com-
ponents [12, 14]. However, with the termination of the primary
insult, this process may be reversible due to increased matrix
degradation and decreased release of cytokines during the reso-
lution phase as has been demonstrated in the animal model of
puromycin aminonucleoside-induced nephrosis [15]. However, if
the primary injury persists or the release of cytokines continues, so
will the accumulation of matrix eventually leading to the accumu-
lation of altered extracellular matrix. The latter may change the
function of cells and thus may hamper the recovery process.
Important mitogens for fibroblasts include insulin-like growth
factor (IGF-1), platelet-derived growth factor (PDGF), endothe-
lin-1, epidermal growth factor (EGF), and transforming growth
factor-a (TGF-a) [16–18]. Fibroblasts in primary cultures derived
from kidneys with early stages of interstitial renal disease show
altered proliferation of fibroblasts compared to fibroblasts derived
from normal kidneys [19].
Morphine is an active metabolite of heroin and has been
incriminated for the effect of heroin on target organs [20]. In the
past, we examined the effect of heroin as well as morphine in
animal experiments [5]. Since the majority of cells in culture are
unable to metabolize heroin to morphine, we preferred to use
morphine in in vitro experiments. Data on the effect of morphine
on fibroblasts in general is scanty and on kidney fibroblasts, in
particular, is not available [21]. In the present study we examined
the effect of morphine on the proliferation as well as apoptosis of
kidney fibroblasts.
METHODS
Kidney fibroblasts
Cultured rat kidney fibroblasts (NRK-49F ATCC Cat # CRL
1570) were obtained from the American Tissue Cell Collection
(Rockville, MD, USA). These cells were plated in 75 cm2 flasks
and incubated in media containing DMEM (GIBCO, Grand
Island, NY, USA), penicillin (50 units/ml; GIBCO), streptomycin
(50 mg/ml; GIBCO) and 10% fetal calf serum (GIBCO) in an
environment of 5% CO2 and 95% air at 37°C. Kidney fibroblasts
were allowed to grow to confluence for five to seven days before
being subcultured.
Source of reagents
Morphine was dissolved in normal saline, stocked at a concen-
tration of 1022 M and used in concentrations of 10214 to 1024 M
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(National Institute on Drug Abuse, Bethesda, MD, USA);
[3H]thymidine was stocked in a concentration of 16.3 Ci/mmol
(Dupont NEN, Cambridge, MA, USA); Hoechst (H)-33342 was
used in a concentration of 1 mg/ml (Molecular Probes, Inc.,
Eugene, OR, USA); propidium iodide was used in a concentra-
tion of 1 mg/ml (Sigma Chemical Company, St. Louis, MO, USA);
mouse anti-p53 antibody was used in a concentration of 1 mg/ml
(Oncogene Research Products, Cambridge, MA, USA). The
APOBrDU kit was obtained from Pharmingen (San Diego, CA,
USA).
Cell proliferation studies
Equal numbers of kidney fibroblasts (10,000 cells/well) were
plated in 24-well culture plates and incubated in Dulbecco’s
modified Eagle medium containing 10% fetal calf serum (FCS),
penicillin and streptomycin. Cells grew to subconfluence within
two to three days. Subconfluent cells were growth arrested for 72
hours by incubating in DMEM containing 1% ITS (insulin,
selenium, transferrin) and 0.5% bovine serum albumin (BSA).
Cells were washed twice with phosphate buffered saline (PBS)
and incubated in RPMI 1640 containing either buffer alone
(control) or morphine (10212 M to 1024 M) for 24 hours at 37°C.
At the end of the incubation period, the cells were washed twice
with PBS, trypsinized and counted in a hemocytometer. Six sets of
experiments (each in quadruplicate) were carried out.
To determine the effect of morphine on mitotic index of kidney
fibroblasts, equal numbers of growth arrested subconfluent cells
were incubated with media containing either buffer alone (con-
trol), or variable concentrations of morphine (10214 to 1026 M)
for 24 hours. At the end of the incubation period, cells having two
nuclei were counted in eight random fields. We calculated the
percentage of cells having two nuclei in each condition. Four sets
of experiments were carried out, each in triplicate.
To determine the effect of morphine on the size of kidney
fibroblasts we evaluated the number of cells per microgram of
cellular protein with or without morphine treatment. Subse-
quently, we calculated the mean protein content of each cell in
different groups. In brief, equal numbers of growth arrested
subconfluent cells were incubated in media containing either
buffer or variable concentrations of morphine (10214 to 1026 M)
for 48 hours. At the end of the incubation period, cells were
trypsinized and an aliquot from each sample was counted in a
hemocytometer and the total number of cells in each well was
determined. The rest of the cells were washed twice with PBS and
pelleted after centrifugation. Protein content of each pellet was
assayed by a BCA kit (Pierce) and the number of cells per
microgram of cellular protein was calculated for each sample.
Four sets of experiments were performed, each in triplicate.
[3H]thymidine incorporation studies
To determine the dose response effect of morphine on the
synthesis of DNA by kidney fibroblasts, equal numbers of cells
(10,000 cells/well) were plated on 24 well plates. Cells were grown
to subconfluence and then growth arrested for 72 hours. Cells
were washed twice with PBS and incubated in DMEM containing
either buffer alone (control) or variable concentrations of mor-
phine (10214 to 1026 M) for 48 hours at 37°C. At 42 hours, an
aliquot of DMEM containing 0.25 mCi of [3H]thymidine was
added to each well and incubation continued for six hours. At the
end of the incubation period cells were washed three times with
cold PBS, 200 ml of 5% trichloroacetic acid (TCA) added to each
well and cells incubated at 4°C for 60 minutes. The TCA
supernatant was removed and 200 ml of 0.25 N NaOH was added
to each well. The cells were kept at room temperature overnight
after which the contents of each well was counted in a scintillation
counter. Results of thymidine incorporation were used as a
measure of cellular proliferation. Three sets of experiments (four
wells for each experiment) were carried out.
H-33342 and propidium iodide staining
H-33342 stains the nuclei of live cells and identifies apoptotic
cells by increased fluorescence, whereas propidium iodide co-
stains dead cells. Double staining by these two agents provides the
percentage of live, apoptotic and necrosed cells under control and
experimental conditions. To determine the effect of morphine on
kidney fibroblast apoptosis, equal numbers of cells (10,000 cells/
well) were plated in 24-well plates. After 48 hours, cells were
washed twice with PBS and incubated in media (DMEM 1 1%
FCS) containing either buffer (control) or variable concentrations
of morphine (10210 M to 1024 M) for 24 hours. At the end of the
incubation period, cells were incubated with H-33342 (1 mg/ml)
for seven minutes at 37°C. Subsequently cells (without a wash)
were placed on ice and propidium iodide (final concentration, 1
mg/ml) was added to each well. Cells were incubated with the dyes
for 10 minutes on ice, protected from light, and examined under
ultraviolet light. The percentage of live, apoptotic and necrosed
cells were recorded in eight random fields. Nine hundred to 1400
cells were examined for different variables in each experiment.
Four sets of experiments were carried out.
Detection of kidney fibroblast apoptosis by the TUNEL method
Using the TUNEL (Terminal deoxy transferase Uridine
triphosphate Nick End-labeling) method, subconfluent kidney
fibroblasts were incubated in media (DMEM 1 1% FCS) con-
taining either buffer (control) or variable concentrations of mor-
phine (10210 to 1026 M) for 24 hours. At the end of the incubation
period, cells were stained using an APOBrDU kit (Pharmingen,
San Diego, CA, USA). Percentage of apoptotic cells was recorded
under an immunofluorescence microscope. Four sets of experi-
ments were performed.
Detection of fibroblast apoptosis by DNA end-labeling
This is a sensitive method for detection of apoptosis. Briefly,
equal numbers of fibroblasts were plated on 100 mm Petri dishes
containing media for 24 hours. Subsequently, the cells were
washed twice with PBS and incubated in media containing either
buffer (control) or morphine (10212 M to 1026 M) for 24 hours. At
the end of the incubation period, the cells were washed and
centrifuged at 800 rpm for 10 minutes at room temperature. The
supernatants were discarded, the pellet resuspended in DNA lysis
buffer [10 mM Tris, pH 7.4, 1.5 mM EDTA (ethylenediaminetet-
raacetic acid), pH 8.0, and 1% SDS) and incubated with 5 ml/ml
proteinase K (Promega, Madison, WI, USA] overnight at 37°C.
The DNA was extracted twice with phenol:chloroform (1:1) and
twice with chloroform:isoamyl alcohol (24:1). DNA was precipi-
tated overnight at 220°C in a 0.3 mM final concentration of Na
acetate, 8 ml of 1 M MgSO4z7H2O and 2.5 volumes of absolute
ethanol. The samples were centrifuged at 10,000 rpm for 30
minutes at 4°C, in an Eppendorf 5415C centrifuge and washed
twice with 70% ethanol. The pellets were dried in a speed-vac for
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10 minutes. The pellets were resuspended in TE buffer (10 mM
Tris and 1 mM EDTA) and DNA concentrations were determined
by reading the absorbance at 260 nm. Five micrograms of isolated
DNA from control and morphine treated fibroblasts were end-
labeled with 5U Klenow polymerase (Promega) in the presence of
10 mM Tris (pH 7.5), 5 mM MgSO4z7H2O, and 0.5 ml of
32P dCTP
(DuPont NEN, Boston, MA, USA) for 10 minutes at room
temperature. The reaction was stopped by adding 10 mM EDTA.
The labeled DNA were purified by Quick Spin nucleotide removal
columns (Qiagen). The end-labeled DNA were electrophoresed
on a 1.8% agarose gel at 5 volts per cm in 0.5X TE buffer
containing 10 mg/ml ethidium bromide. After drying the gel on a
slab gel dryer for 45 minutes at 40°C, radiolabeled fragments were
visualized by exposure to Kodak X-ray film at 270°C for 30
minutes to three hours.
Protein extraction
Equal numbers (10,000) of kidney fibroblasts were seeded in
100 mm Petri dishes and grown to subconfluence. Subsequently,
cells were washed twice with PBS and incubated in medium
containing either buffer (control) or morphine (10212 M to 1024
M) for two hours. In parallel experiments, equal numbers of
subconfluent kidney fibroblasts were incubated with morphine
(10212 M and 1028 M) for variable time periods (2, 4 and 6 hr). At
the end of the incubation periods, cells were washed twice with
PBS and incubated with 100 ml of PBSTDS lysis buffer for 30
minutes at room temperature. Cells were scraped and protein was
assayed with a BCA kit (Pierce, Rockford, IL, USA).
Western blotting
The proteins (20 mg/lane) extracted from cell lysates were
separated on 4 to 20% gradient polyacrylamide gel electrophore-
sis and transferred onto a nitrocellulose membrane using a
BIORAD Western blotting apparatus. Nitrocellulose membranes
were then processed further for p53 using mouse anti-p53 at 1
mg/ml concentration, one hour at room temperature using HRP
(horseradish peroxidase) labeled with secondary goat anti-mouse
antibody (Pierce), and then the blots were developed using
chemiluminescence (ECL; Amersham).
RNA extraction and identification of growth associated genes
Equal numbers of subconfluent and growth-arrested cultured
rat kidney fibroblasts were treated either with vehicle (control) or
morphine (10212 M and 10210 M) for 10, 30, 60 and 120 minutes.
At the end of the incubation periods, cells were washed twice with
PBS and then treated with lysis buffer. Total RNA was extracted
from lysates of cultured rat kidney fibroblasts. Aliquots of total
RNA were treated with formamide and formaldehyde, electro-
phoresed in a 1.2% agarose-formaldehyde gel, and transferred to
HYBOND-N membranes. The gel was stained with ethidium
bromide to determine the size of RNA. cDNA probes specific for
c-fos, c-jun and c-myc (gift from Dr. Sanjeev Gupta, Liver
Research Center, Albert Einstein College of Medicine, Bronx,
NY, USA) were used for hybridization after [32P]dCTP labeling
by random-prime labeling. Filters were hybridized at 42°C for 16
hours with the labeled specific cDNA probe. The membranes
were washed to a final high stringency of 0.2 3 SSC, 0.1% SDS for
20 minutes at 65°C. After washing, the membranes were kept in
contact with XAR-5 film and intensifying screen at 270°C and
developed. The membranes were stripped to remove the hybrid-
ized probe and reprobed with GAPDH to ascertain that similar
amounts of RNA were applied to the gel. Densitometric analysis
of the ratios between c-fos/c-jun/c-myc and GAPDH expression
was determined for control as well as morphine treated cells.
Three sets of experiments were carried out and results were
calculated as mean 6 SEM.
Statistical analysis
Comparison of cultured rat kidney fibroblast proliferation and
matrix accumulation between control and experimental condi-
tions was carried out by an unpaired Student’s t-test. When more
than two groups were involved, intergroup comparisons were
performed by analysis of variance. A Newman-Keuls multiple
range test was used to calculate a q value. Results are represented
as means 6 SEM. Difference was considered to be statistically
significant at P , 0.05.
RESULTS
Effect of morphine on proliferation of kidney fibroblasts
The 24 hour effect of morphine on the proliferation of fibro-
blasts is shown in Figure 1. Morphine at higher concentrations
(1026 M to 1024 M) induced suppression of kidney fibroblast
proliferation (Fig. 1). Morphine enhanced (P , 0.001) the
proliferation of kidney fibroblasts at a lower concentration (mor-
phine, 10212 M, 112.2 6 10.1 vs. control, 67.5 6 2.0 3 104
cells/well; 24 hr). Similarly, at 48 hours, morphine enhanced
kidney fibroblast proliferation at lower concentrations (Fig. 2).
This was further evident from the 48 hour effect of morphine on
the synthesis of DNA (Fig. 3). At lower concentrations, morphine
treated cells showed a greater percentage of mitotic index when
compared to untreated cells (Fig. 4). However, at lower concen-
trations morphine treated cells contained a much lower mean
protein content when compared to control cells (control, 0.66 6 0.15;
morphine 10214 M, 0.44 6 0.01; morphine, 10212 M, 0.23 6
0.02; morphine, 10210 M, 0.39 6 0.02; morphine, 1028 M, 0.47 6 0.11;
morphine, 1026 M, 0.88 6 0.08 ng protein/cell). A decrease in the
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Fig. 1. Effect of morphine on kidney fibroblast proliferation at 24 hours.
Equal numbers of growth arrested kidney fibroblasts were incubated in
DMEM containing either buffer alone (control) or variable concentra-
tions of morphine (10212 M to 1024 M) for 24 hours at 37°C (N 5 6). *P ,
0.001 compared with control and morphine 10210 M to 1024 M; **P , 0.01
compared with morphine, 1026 M to 1024 M; ***P , 0.001 compared with
control.
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mean cell protein content in the morphine (10214 to 10212 M) treated
group may be related to the accumulation of an increased number of
younger (dividing) cells with a smaller size.
Effect of morphine on kidney fibroblast apoptosis using the
TUNEL (APOBrdu) method
Morphine in concentrations of 1028 to 1026 M showed en-
hanced apoptosis of kidney fibroblasts at 24 hours (control, 0.8 6
0.1%, morphine, 10210 M, 2.1 6 0.7%; morphine, 1028 M, 5.6 6
1.0%; morphine, 1026 M, 9.0 6 0.7%; P , 0.001, control vs.
morphine, 1026 M; P , 0.01, control vs. morphine, 1028 M). These
results further confirm that morphine at higher concentrations
promotes kidney fibroblast apoptosis.
Effect of morphine on apoptosis of kidney fibroblasts by
H-33342 staining
The effect of morphine on kidney fibroblast apoptosis at 48
hours is shown in Figure 5. Morphine promoted apoptosis of
kidney fibroblasts at higher concentrations (1028 M to 1024 M).
The percentage of apoptotic cells was higher at 48 hours when
compared to the percentage of apoptotic cells at 24 hours
(TUNEL method). These results suggest that morphine-induced
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Fig. 2. Effect of morphine on kidney fibroblast proliferation at 48 hours.
Equal numbers of growth arrested subconfluent kidney fibroblasts were
incubated in media containing either buffer (control) or variable concen-
trations of morphine (10214 to 1026 M) for 48 hours. At the end of the
incubation period, number of cells as well as protein content per well were
measured (N 5 4). **P , 0.001 compared with morphine, 10214 to 1028
M; *P , 0.001 compared with morphine, 10214 M, 10210 M and 1028 M;
***P , 0.05 compared with morphine, 10214 M and 1028 M.
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Fig. 3. Effect of morphine on kidney fibroblast DNA synthesis. Equal
numbers of growth arrested kidney fibroblasts were incubated in media
(DMEM) containing either buffer alone (control) or variable concentra-
tions of morphine (10214 to 1026 M) for 48 hours at 37°C. At 42 hours, an
aliquot of media containing [3H]thymidine was added to each variable. At
the end of the incubation period cells were harvested and radioactivity was
measured (N 5 3). *P , 0.001 compared with control and morphine, 1026
M; **P , 0.01 compared with control and 1026 M. ***P , 0.05 compared
with control; aP , 0.01 compared with morphine, 10214 M; bP , 0.05
compared with morphine, 10214 M; cP , 0.01 compared with morphine,
1026 M.
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Fig. 4. Effect of morphine on kidney fibroblast mitotic index. Equal
numbers of growth arrested kidney fibroblasts were incubated in media
containing either buffer (control) or variable concentrations of morphine
(10214 to 1026 M) for 24 hours. At the end of the incubation period, the
percentage of cells with two nuclei was counted (N 5 4). *P , 0.001
compared with control, morphine, 10214 M, 1028 to 1026 M; **P , 0.01
compared with morphine, 10210 M; ***P , 0.05 compared with control,
morphine, 10214 M, 1028 to 1026 M.
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Fig. 5. Effect of morphine on fibroblast apoptosis. Equal numbers of
kidney fibroblasts were incubated in media (DMEM 1 1% FCS) contain-
ing either buffer (control) or variable concentrations of morphine (10210
M to 1024 M) for 24 hours. At the end of the incubation period, cells were
stained with H-33342 (1 mg/ml) and propidium iodide. Percentage of live,
apoptotic and necrosed cells were recorded in eight random fields (N 5 4).
*P , 0.001 compared with control; **P , 0.05 compared with control;
***P , 0.001 compared with morphine, 1026 M and 1024 M.
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apoptosis of kidney fibroblasts may be contributing to morphine-
induced suppression of fibroblast proliferation.
Effect of morphine on fibroblast DNA fragmentation
The effect of morphine on fibroblast DNA fragmentation
(DNA end-labeling) is shown in Figure 6. Control cells (Lane C)
did not show any DNA fragmentation. Fibroblasts treated with
higher concentrations (10210 M to 1026 M) of morphine showed
DNA fragmentation (integer multiples of 180 base pairs) in the
form of a ladder pattern.
Effect of morphine on the synthesis of p53 by kidney
fibroblasts
The effect of morphine on the synthesis of p53 by kidney
fibroblasts is shown in Figures 7 and 8. Morphine enhanced the
synthesis of p53 by kidney fibroblasts in a dose dependent manner
(Fig. 7). Morphine treated cells at a lower concentration (10212
M) showed minimal synthesis of p53 by kidney fibroblasts, while
morphine at a concentration of 1024 M induced the maximal
synthesis of p53 by cultured rat kidney fibroblast cells. Synthesis of
p53 by morphine treated kidney fibroblasts showed a plateau at
four hours (Fig. 8). Since morphine promoted apoptosis only at
higher concentrations, it appears that morphine-induced en-
hanced synthesis of p53 may be playing a role in the induction of
apoptosis.
Effect of morphine on mRNA expression of early growth
related genes
The effects of morphine on mRNA expression of early growth
related genes are shown in Figures 9, 10, 11 and Table 1 (means 6
SEM are from three sets of experiments). Morphine (10210 M)
increased mRNA expression of c-jun by 1.7-fold at 10 minutes
(Fig. 9 and Table 1), whereas morphine (10212 M) enhanced
expression of c-fos by 2.3-fold (Fig. 10 and Table 1). Morphine
(10210 M) increased expression of c-myc by 1.6-fold at 120 minutes
(Fig. 11 and Table 1).
DISCUSSION
The present study demonstrates that morphine modulates
kidney fibroblast proliferation. Morphine enhances proliferation
at lower concentrations and causes apoptosis at higher concen-
trations. Morphine at lower concentrations also modulates
mRNA expression of c-fos, c-jun and c-myc on kidney fibroblasts.
Morphine at higher concentrations enhances the production of
p53 by kidney fibroblasts.
Morphine has been reported to induce a direct modulatory
effect on the proliferation of different cells of immune origin
[22–24]. Recently, DiFrancesco et al demonstrated that morphine
blocks the entry of stimulated EL2 rat fibroblasts from G0/G1 to
S1 phase [21]. However, these investigators did not study the
effect of morphine on fibroblasts under a basal state. Moreover,
these investigators used morphine at high concentrations which
are likely to cause suppression of fibroblast proliferation. Mor-
phine at pharmacological doses provides a blood concentration of
1028 M or lower. The effect of these concentrations was not
evaluated by these investigators. On the contrary, we have used
morphine at pharmacological (1028 M) as well as at lower
concentrations (physiological, 10212 M) in the present study. At
higher concentrations morphine suppresses the proliferation of
fibroblasts and our results are consistent with DiFrancesco et al
[21]. Since morphine promotes apoptosis of fibroblasts at higher
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Fig. 6. DNA end-labeling of control and morphine treated kidney fibro-
blasts. DNA was isolated from control (C) and morphine (10212 to 1026
M) treated kidney fibroblasts and end-labeled. Morphine (10210 M to 1026
M) treated fibroblasts showed a classic ladder pattern (integer multiples of
180 base pairs).
Fig. 7. Effect of morphine on synthesis of p53 by kidney fibroblasts
(Western blot). Equal numbers of kidney fibroblasts were seeded in 100
mm Petri dishes and grown to subconfluence. Equal numbers of subcon-
fluent and growth arrested cells were incubated in medium containing
either buffer (control), or morphine (10212 M to 1024 M) for two hours. At
the end of the incubation, cells were lysed, proteins were extracted and
probed using mouse anti-p3 (1 mg/ml). Western blot shows that morphine
at higher concentrations enhances the production of p53.
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concentrations, morphine-induced cell suppression may partly
attributed to the occurrence apoptosis. First, apoptotic cells do
not proliferate and may not contribute to the proliferating cell
pool. Second, cell numbers decline because many of the apoptotic
cells may detach from the substrate and may not be available at
the time of cell counting.
Apoptosis is a highly regulated form of cell death and is distinct
from necrosis. Cells that die by apoptosis go through two sequen-
tial cycles such as commitment and execution [25, 26]. The
duration of the commitment phase may be quite variable ranging
from minutes to days, whereas the execution phase is relatively
constant in duration ranging from 15 to 60 minutes. Cells during
the commitment phase have normal morphology, whereas cells
show classical features of apoptosis during the execution phase
[25, 26]. Several genes have been implicated to regulate apoptosis
[26–28]. In humans, these include p53, c-Myc, and Bcl-2. The gene
p53 has been demonstrated to play an important role in apoptosis
induced by DNA damage [29, 30]. It is one of the genes most
Fig. 8. Time course effect of morphine on the
production of p53 by kidney fibroblasts
(Western blot). Equal numbers of subconfluent
and growth arrested kidney fibroblasts were
incubated with morphine (10212 M and 1028 M)
for variable time periods (2, 4 and 6 hr). At the
end of the incubation periods cells were lysed,
proteins were extracted and probed for p53.
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Fig. 9. Effect of morphine on mRNA expression of c-jun on kidney fibroblasts. The upper panel shows mRNA expression of c-jun by buffer (C) or
morphine (10212 M and 10210 M) treated kidney fibroblasts at indicated time periods. The lower panel shows expression of GAPDH by control and
morphine treated fibroblasts at the indicated times.
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Fig. 10. Effect of morphine on mRNA expression of c-fos on kidney fibroblasts. The upper panel shows mRNA expression of c-fos by kidney fibroblasts
after treatment with either buffer (C) or morphine (10212 M and 10210 M) for 10, 30, 60 and 120 minutes. The lower panel shows expression of GAPDH
by kidney fibroblasts at the indicated times.
Morphine, M
10 minutes
10 –12C 10 –10
Morphine, M
30 minutes
10 –12C 10 –10
Morphine, M
60 minutes
10 –12C 10 –10
Morphine, M
120 minutes
10 –12C 10 –10
C-myc
GAPDH
Fig. 11. Effect of morphine on mRNA expression of c-myc by kidney fibroblasts. The upper panel shows mRNA expression of c-myc by buffer (C) or
morphine (10212 M and 10210 M) treated fibroblasts at the indicated time periods. The lower panel shows GAPDH expression by buffer or morphine
treated fibroblasts at the same time periods.
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commonly mutated in human malignancies [29]. The product of
the p53 gene encodes a putative transcription factor and interacts
with a variety of proteins involved in the progression of the cell
cycle [29, 30]. We hypothesize that morphine-induced enhanced
synthesis of p53 may have mediated fibroblast apoptosis.
Renal interstitial scarring is a major component of heroin
associated nephropathy. We hypothesize that drug addicts in the
beginning use a lesser amount of morphine that may initiate the
proliferation of kidney fibroblasts as shown by physiological
concentrations of morphine. However, gradually, drug addicts
develop a tolerance to morphine, and to get a similar effect they
may have to increase the dosage. Morphine at higher concentra-
tions may lead to the suppression of fibroblast proliferation by
promoting apoptosis. Hence, in due time morphine has the
potential to induce a lesion characterized by initial hyperplasia
and subsequent hypoplasia of interstitial cells.
The majority of patients with human immunodeficiency virus
(HIV)-associated nephropathy are intravenous drug abusers [31,
32]. Drugs have been implicated to contribute to the development
of HIV-associated nephropathy [31, 32]. Cocaine has been re-
ported to enhance replication of the HIV virus [33]. Morphine
activates peripheral mononuclear cells to secrete TGF-b [34]. The
latter has been demonstrated to enhance the expression of HIV-1
genes in cultured mesangial cells [35]. Renal interstitial scarring is
a predominant component of HIV-associated nephropathy. It is
likely that drugs such as morphine may also be contributing to the
development as well as progression of renal interstitial scarring in
patients with HIV-associated nephropathy.
Recently, Friedman and Rao suggested that the contaminants
in street heroin contributed to the increased incidence of heroin-
associated nephropathy in the 1980s and earlier periods in the
metropolitan area of New York City [36]. However, these authors’
stipulation was based on two circumstantial observations (noted in
1990s): (1) there was a decrease in the incidence of heroin-
associated nephropathy in the metropolitan area, and (2) there
was an availability of contaminant-free (relatively pure) street
heroin. These authors linked these two observations and inferred
that contaminants in the street heroin were responsible for the
previously reported incidence of heroin-associated nephropathy
in the metropolitan area [36]. Since there has been an increase in
the incidence (of similar magnitude as reported for heroin
nephropathy in 1980s) of another glomerulopathy (HIV-associ-
ated nephropathy) in the intravenous drug abuser population of
the New York City metropolitan area, we differ from the inter-
pretation of these authors [36]. We speculate that intravenous
drug abusers are susceptible for developing renal lesions as well as
HIV infection. Because of this dual susceptibility, this segment of
the New York City area population is now more likely to develop
HIV-associated nephropathy. We are not suggesting that HIV has
not contributed to the development of this glomerular lesion.
There are enough instances where HIV infection has been
demonstrated to be solely responsible for the development of
HIV-associated nephropathy [37]. However, this must not
dampen our enthusiasm to evaluate the role of heroin in the
development of the renal lesion.
We conclude that morphine directly modulates the prolifera-
tion of kidney fibroblasts and has a bimodal action. The present
study provides a mechanistical insight into the development of
renal interstitial scarring in patients with heroin addiction.
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APPENDIX
Abbreviations used in this article are: BSA, bovine serum albumin;
EDTA, ethylenediaminetetraacetic acid; EGF, epidermal growth factor;
FCS, fetal calf serum; HIV, human immunodeficiency virus; HRP, horse-
radish peroxidase; IGF-1, insulin-like growth factor; PBS, phosphate
buffered saline; PDGF, platelet-derived growth factor; TCA, trichloroace-
tic acid; TE buffer, Tris and EDTA; TGF-a, transforming growth factor-
alpha; TUNEL, terminal deoxy transferase uridine triphosphate nick
end-labeling.
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